The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula (I) where A, B, U, V, Z, W1, W2, W3, and R1-R6 are described herein.
本发明涉及突变型
异柠檬酸脱氢酶(mt-IDH)蛋白的
抑制剂,该
抑制剂具有新变态活性,可用于治疗细胞增殖障碍和癌症,其式(I)中的A、B、U、V、Z、W1、W2、W3和R1-R6如本文所述。